Showing 7851-7860 of 8648 results for "".
- Sight Sciences Names New Chief Operating Officer and General Counselhttps://modernod.com/news/sight-sciences-names-new-chief-operating-officer-and-general-counsel/2477930/Sight Sciences announced two key hires: Sam Park, joining as Chief Operating Officer, and Jeremy Hayden, who joins as General Counsel and Chief Compliance Officer. “We are excited to be able to add leaders with the outstanding track records of Sam and Jeremy as Sight Sciences continu
- Johnson & Johnson Vision Donates $320K to Support Practitioners and Schools of Optometry Impacted by COVID-19https://modernod.com/news/johnson-johnson-vision-donates-320k-to-support-practitioners-and-schools-of-optometry-impacted-by-covid-19/2477924/As part of ongoing initiatives to help support eye care in the wake of COVID-19, Johnson & Johnson Vision announced donations to Optometry Cares, the charitable foundation of The American Optometric Association (AOA) Foundation and the American Academy of Optometry Foundation (AAOF). A
- Versant Health Debuts New Eye Care Resource Centerhttps://modernod.com/news/versant-health-debuts-new-eye-care-resource-center/2477925/In celebration of Healthy Vision Month this July, Versant Health has launched a new resource center providing tools that enable people to take command of their vision health. Designated by the National Eye Institute, Healthy Vision Month is dedicated to highlighting the importance of eye h
- Survey: Use of Virtual Education Soars; Telemedicine Remains a Small Percentage of Volumehttps://modernod.com/news/survey-use-of-virtual-education-soars-telemedicine-remains-a-small-percentage-of-volume/2477922/Since the onset of the COVID-19 pandemic, the majority of ophthalmologists and optometrists are ‘very likely’ to participate in virtual education programs, while the percentage of those using telemedicine remains low compared to traditional care. That according to a recent survey conducted
- Gilead Looking to Test Easier-To-Use, Inhaled Version of Remdesivirhttps://modernod.com/news/gilead-to-begin-human-trials-for-the-inhaled-version-of-coronavirus-drug-remdesivir/2477919/Gilead Sciences said Monday that it hopes to begin clinical trials this summer evaluating an inhaled formulation of remdesivir, administered via a nebuliser, to patients with COVID-19. The experimental antiviral, which the FDA authorized for emergency use in early May, is currently given intraven
- UK to Test Weekly, Swabless COVID-19 Screening for Health Care Workers, Students and Morehttps://modernod.com/news/uk-to-test-weekly-swabless-covid-19-screening-for-health-care-workers-students-and-more/2477918/The UK government will begin testing a new, swabless coronavirus test, designed to be completed at home on a weekly basis by spitting into a collection tube, according to a FierceBiotech
- ImprimisRx’s Patented Klarity-C 0.1% Cyclosporine Preservative-Free Formulation May Now Be Prescribed By Florida’s 2,000 Optometristshttps://modernod.com/news/imprimisrxs-patented-klarity-c-0-1-cyclosporine-preservative-free-formulation-may-now-be-prescribed-by-floridas-2000-optometrists/2477907/ImprimisRx announced its Klarity-C preservative-free formulation (0.1% cyclosporine emulsion) may now be prescribed by Florida’s nearly 2,000 optometrists as a result of the Florida Board of Optometry’s recent additions to its Formulary of Topical Ocular Pharmaceutical Agents. Klarity-C w
- Bionic Sight Doses First Patient in a Phase 1/2 Clinical Trial of a New Investigational Treatment for Retinitis Pigmentosahttps://modernod.com/news/bionic-sight-llc-doses-first-patient-in-a-phase-1-2-clinical-trial-of-a-new-investigational-treatment-for-blindness-caused-by-retinitis-pigmentosa/2477902/Bionic Sight announced that it has dosed the first patient in the company’s phase 1/2 clinical trial of BS01, an optogenetic gene therapy for patients with retinitis pigmentosa. This is an important step toward bringing BS01 forward as a treatment to enable patients with retinal degenerative dise
- Study: Dexamethasone Reduces Death In Hospitalized Patients With Severe Respiratory Complications of COVID-19https://modernod.com/news/scientists-hail-dexamethasone-as-major-breakthrough-in-treating-covid-19/2477901/Results of a large trial show that the inexpensive and widely used steroid dexamethasone has the potential to save lives in patients with severe cases of COVID-19. In what some scientists are calling a “major breakthrough” in the coronavirus pandemic, dexamethasone, which is used to reduce
- COVID-19 Spikes in Certain States Spark Concerns for Vulnerable Rural Hospitalshttps://modernod.com/news/covid-19-spikes-in-certain-states-spark-concerns-for-vulnerable-rural-hospitals/2477897/The COVID-19 pandemic is starting to reach rural areas as cases in several states start to rise with economies reopening, according to a FierceHealthcare